Schizophrenia, anitpsychotics and cardiovascular risk

Abstract

Cardiovascular deaths are a significant cause of mortality among patients with schizophrenia. Routine monitoring of physical health, preferential use of metabolically neutral antipsychotics and lifestyle education are critical to minimizing risk of antipsychotics treatment.

Keywords

• schizophrenia
• minimizing risk
• antipsychotics treatment